| Literature DB >> 32436265 |
Soumitra Tole1,2,3, Priya Dhir4, Jakob Pugi1, Luke J Drury5, Sheila Butchart6, Michelle Fantauzzi6, Jacob C Langer7, Jillian M Baker1,4,8, Victor S Blanchette1, Melanie Kirby-Allen1, Manuel D Carcao1,9.
Abstract
Hereditary spherocytosis (HS) is a common inherited haemolytic anaemia attributed to disturbances in five different red cell membrane proteins. We performed a retrospective study of 166 children with HS and describe the clinical phenotype according to the genotype. In 160/166 (97%) children with HS a disease-causing mutation was identified. Pathogenic variants in ANK1, SPTB, SLC4A1 and SPTA1 were found in 49%, 33%, 13% and 5% of patients. Children with SLC4A1-HS had the mildest phenotype, showing the highest haemoglobin (P < 0·001), lowest reticulocyte counts (P < 0·001) and lowest unconjugated bilirubin levels (P = 0·006), and none required splenectomy in childhood (P < 0·001). Conversely, children with autosomal recessive SPTA1-HS had the most severe clinical phenotype, with almost all patients undergoing splenectomy in early childhood. Patients with ANK1 and SPTB variants showed a similar clinical phenotype. Within each gene, variant type or location did not predict disease severity or likelihood of splenectomy. Among patients with a genetic diagnosis, 47 (29%) underwent splenectomy (23 partial; 24 total) while 57 (36%) underwent cholecystectomy. Total splenectomy led to greater improvements in haemoglobin (P = 0·02). Select use of genetic testing (especially in patients without a family history) may help predict clinical phenotype in childhood and guide family counselling.Entities:
Keywords: genotype; hereditary spherocytosis; splenectomy
Mesh:
Year: 2020 PMID: 32436265 DOI: 10.1111/bjh.16750
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998